BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,585 | +0.7% | 60,613 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,542 | -13.8% | 60,613 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $7,588 | -93.6% | 60,913 | -92.2% | 0.00% | -94.7% |
| Q4 2022 | $117,814 | -99.9% | 784,278 | -37.6% | 0.02% | -32.1% |
| Q3 2022 | $169,451,000 | -38.5% | 1,256,309 | -32.0% | 0.03% | -20.0% |
| Q2 2022 | $275,527,000 | +5.8% | 1,847,935 | +21.0% | 0.04% | +34.6% |
| Q1 2022 | $260,415,000 | -34.3% | 1,526,825 | -0.7% | 0.03% | -27.8% |
| Q4 2021 | $396,425,000 | +24.8% | 1,537,723 | +32.1% | 0.04% | +20.0% |
| Q3 2021 | $317,716,000 | -30.1% | 1,163,839 | -42.7% | 0.03% | -28.6% |
| Q2 2021 | $454,624,000 | +100.7% | 2,030,661 | -2.1% | 0.04% | +82.6% |
| Q1 2021 | $226,559,000 | +76.5% | 2,074,906 | +31.8% | 0.02% | +76.9% |
| Q4 2020 | $128,379,000 | +54.8% | 1,574,821 | +31.5% | 0.01% | +30.0% |
| Q3 2020 | $82,913,000 | +318.3% | 1,197,644 | +303.2% | 0.01% | +400.0% |
| Q2 2020 | $19,822,000 | – | 297,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $22,333,808 | 17.21% |
| Quinn Opportunity Partners LLC | 262,071 | $39,368,306 | 4.82% |
| Temasek Holdings (Private) Ltd | 4,378,022 | $657,666,465 | 3.84% |
| PARUS FINANCE (UK) Ltd | 29,988 | $4,504,797 | 3.06% |
| Top Ace Asset Management Ltd | 20,000 | $3,004,400 | 2.21% |
| Artia Global Partners LP | 37,108 | $5,574,364 | 2.12% |
| Boston Common Asset Management, LLC | 269,803 | $40,530 | 1.94% |
| FLOSSBACH VON STORCH AG | 3,282,723 | $493,130,649 | 1.88% |
| Redwood Investments, LLC | 87,540 | $13,150,259 | 1.76% |
| Baader Bank Aktiengesellschaft | 238,800 | $35,881,130 | 1.74% |